Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 139 of the 140 references it cites were found in a registry or an index.

Benefits and Risks of Pharmacological Treatments for Essential Tremor

Abstract

Essential tremor can cause significant functional disability in some patients. The arms are the most common body part affected and cause the most functional disability. The treatment of essential tremor includes medications, surgical options and other forms of therapy. Presently there is no cure for essential tremor nor are there any medications that can slow the progression of tremor. Treatment for essential tremor is recommended if the tremor causes functional disability. If the tremor is disabling only during periods of stress and anxiety, propranolol and benzodiazepines can be used during those periods when the tremor causes functional disability. The currently available medications can improve tremor in approximately 50% of the patients. If the tremor is disabling, treatment should be initiated with either primidone or propranolol. If either primidone or propranolol do not provide adequate control of the tremor, then the medications can be used in combination. If patients experience adverse effects with propranolol, occasionally other beta-adrenoceptor antagonists (such as atenolol or metoprolol) can be used. If primidone and propranolol do not provide adequate control of tremor, occasionally the use of benzodiazepines (such as clonazepam) can provide benefit. Other medications that may be helpful include gabapentin or topiramate. If a patient has disabling head or voice tremor, botulinum toxin injections into the muscles may provide relief from the tremor. Botulinum toxin in the hand muscles for hand tremor can result in bothersome hand weakness and is not widely used. There are other medications that have been tried in essential tremor and have questionable efficacy. These drugs include carbonic anhydrase inhibitors (e.g. methazolamide), phenobarbital, calcium channel antagonists (e.g. nimodipine), isoniazid, clonidine, clozapine and mirtazapine. If the patient still has disabling tremor after medication trials, surgical options are usually considered. Surgical options include thalamotomy and deep brain stimulation of the thalamus. These surgical options provide adequate tremor control in approximately 90% of the patients. Surgical morbidity and mortality for these procedures is low. Deep brain stimulation and thalamotomy have been shown to have comparable efficacy but fewer complications have been reported with deep brain stimulation. In patients undergoing bilateral procedures deep brain stimulation of the thalamus is the procedure of choice to avoid adverse effects seen with bilateral ablative procedures. The use of medication and/or surgery can provide adequate tremor control in the majority of the patients.

Overview

Integrity signals

Registry

Crossref · 10.2165/00002018-200326070-00003

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 140 references

Research works printed but not linked: 14

  1. Sevitt, 1971, Practitioner, 207, 677
  2. Winkler, 1971, Trans Am Neurol Assoc, 96, 66
  3. Murray, 1976, Can Med Assoc J, 115, 892
  4. Dupont, 1973, Acta Neurol Scand, 69, 75
  5. Huttunen, 1984, Lancet, II, 857
  6. Britt, 1979, N Engl J Med, 301, 331
  7. Ljung, 1979, N Engl J Med, 301, 1005
  8. Riley, 1979, N Engl J Med, 301, 663
  9. Connor, 1999, Mov Disord, 14, 908
  10. Jimenez-Jimenez, 1994, Acta Neurol (Napoli), 16, 184
  11. Ertan, 2000, Mov Disord, 15, 102
  12. Ohye, 1982, Appl Neurophysiol, 45, 275
  13. Benabid, 1993, Acta Neurochir Suppl (Wien), 58, 39
  14. Bilodeau, 2000, Muscle Nerve, 23, 771, 10.1002/(SICI)1097-4598(200005)23:5<771::AID-MUS15>3.0.CO;2-9 · doi:10.1002/(sici)1097-4598(200005)23:5<771::aid-mus15>3.0.co;2-9

Cited by

See all 106

Metadata

Authors
Lyons, K. E., Pahwa, R., Comella, C. L., Eisa, M. S., Elble, R. J., Fahn, S., Jankovic, J., Juncos, J. L., Koller, W. C., Ondo, W. G., Sethi, K. D., Stern, M. B., Tanner, C. M., Tintner, R., & Watts, R. L.
Affiliations
  • University of Kansas Medical Center (US)
  • Rush University Medical Center (US)
  • Pennsylvania Hospital (US)
  • SIU Medicine (US)
  • Columbia University (US)
  • Baylor College of Medicine (US)
  • Emory University (US)
  • Mount Sinai Hospital (US)
  • Augusta University (US)
  • Parkinson's Institute and Clinical Center (US)
Corresponding author
Pahwa, Rajesh
Venue
Drug Safety
Published
2003
Volume
26
Issue
7
Pages
461-481
ISSN
0114-5916 (ISSN-L)
OpenAlex
W2121739059
Cited by
103
References
140
Citations by year
2026: 1 · 2025: 4 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 5 · 2015: 6 · 2014: 6 · 2013: 2 · 2012: 10
FWCI
0.99
Type
journal article
Language
en
Open access
closed
Locations
  • Drug Safety (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
  • Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
essential tremor, pharmacotherapy, primidone, propranolol, benzodiazepines, beta-blockers, gabapentin, topiramate, botulinum toxin, deep brain stimulation, thalamotomy, surgical treatment, functional disability, tremor control, adverse drug reactions, carbonic anhydrase inhibitors, clonidine, mirtazapine
MeSH terms
Adrenergic Agonists, Anticonvulsants, Clinical Trials as Topic, Electric Stimulation Therapy, Humans, Neuromuscular Agents, Primidone, Risk Assessment, Essential Tremor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Benefits and Risks of Pharmacological Treatments for Essential Tremor. https://app.cochat.ai/papers/10.2165/00002018-200326070-00003
The paper
Lyons, K. E., Pahwa, R., Comella, C. L., Eisa, M. S., Elble, R. J., Fahn, S., Jankovic, J., Juncos, J. L., Koller, W. C., Ondo, W. G., Sethi, K. D., Stern, M. B., Tanner, C. M., Tintner, R., & Watts, R. L. (2003). Benefits and Risks of Pharmacological Treatments for Essential Tremor. Drug Safety. https://doi.org/10.2165/00002018-200326070-00003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.